LLMpediaThe first transparent, open encyclopedia generated by LLMs

DowElanco

Generated by DeepSeek V3.2
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: Dow Chemical Company Hop 4
Expansion Funnel Raw 51 → Dedup 0 → NER 0 → Enqueued 0
1. Extracted51
2. After dedup0 (None)
3. After NER0 ()
4. Enqueued0 ()
DowElanco
NameDowElanco
FateMerged to form Dow AgroSciences
PredecessorDow Chemical Agricultural Products Division, Eli Lilly's Elanco division
SuccessorDow AgroSciences
Founded0 1989
Defunct0 1997
IndustryAgrochemicals
ProductsHerbicides, insecticides, fungicides, seed treatments
ParentDow Chemical Company (60%), Eli Lilly and Company (40%)

DowElanco. It was a major joint venture formed in 1989 between the agricultural divisions of two American industrial giants, The Dow Chemical Company and Eli Lilly and Company. The company was established to combine the resources and expertise of Dow Chemical's Agricultural Products Department with Lilly's Elanco animal health and crop protection business. Operating as a standalone entity, DowElanco quickly became a leading global competitor in the development and marketing of crop protection chemicals and agricultural biotechnology.

History

The formation of DowElanco was announced in late 1988, culminating a period of significant consolidation within the global agrochemical industry. This strategic move was driven by both companies' desires to pool substantial research and development resources and expand their international market reach against established rivals like Monsanto, DuPont, and Ciba-Geigy. The venture officially commenced operations in 1989, with its global headquarters established in Indianapolis, Indiana, leveraging the existing infrastructure of the Elanco division. Throughout the early 1990s, DowElanco pursued an aggressive growth strategy, acquiring several smaller firms and expanding its operations across Europe, Latin America, and Asia. This period was marked by significant investment in biotechnology research, particularly in genetically modified crops, positioning the company at the forefront of the emerging life sciences sector.

Products and operations

DowElanco's portfolio was built on a foundation of legacy products from its parent companies, including the powerful herbicide Trifluralin, originally developed by Eli Lilly and Company. The company was a major producer of sulfonylurea herbicides, such as Nicosulfuron, used extensively in maize cultivation. Its insecticide line featured products like Tefluthrin, a soil-applied compound for controlling corn rootworm. The venture also marketed the fungicide Propiconazole under various brand names for protecting cereals and turfgrass. Beyond traditional chemistry, DowElanco invested heavily in novel seed treatment technologies and early-stage plant biotechnology, developing insect-resistant and herbicide-tolerant traits for major crops. Its global operations encompassed manufacturing facilities, research stations, and sales networks serving farmers in over 100 countries.

Corporate structure

DowElanco was structured as a limited liability company owned 60% by The Dow Chemical Company and 40% by Eli Lilly and Company. This ownership split reflected the relative value of the assets contributed by each parent. The company was governed by a board of directors with representation from both Dow Chemical and Eli Lilly and Company. Day-to-day management was led by a chief executive officer, with key executive positions often filled by personnel from both founding entities. Financially, DowElanco operated with its own balance sheet and reported its results separately, though its performance was consolidated into the financial statements of its parent companies. Major strategic decisions, particularly regarding large-scale capital expenditure or mergers and acquisitions, required approval from the board and the parent firms.

Merger and legacy

In 1997, The Dow Chemical Company exercised its option to purchase the remaining 40% stake from Eli Lilly and Company, dissolving the joint venture. This full acquisition was part of Dow Chemical's strategic pivot to fully integrate life sciences as a core business segment. The assets and operations of DowElanco were immediately folded into a new, wholly-owned subsidiary named Dow AgroSciences. This entity continued to build upon the product pipeline and biotechnology research initiated by DowElanco. The legacy of DowElanco is most evident in the subsequent success of Dow AgroSciences, which became a top-tier agribusiness firm and was later itself acquired by Corteva Agriscience following the merger of Dow Chemical and DuPont. Many of the herbicide and insecticide brands originally developed or commercialized by DowElanco remain in widespread use in global agriculture today.

See also

* Agrochemical industry * History of agriculture in the United States * Joint venture * Monsanto * Syngenta

Category:Agricultural companies of the United States Category:Defunct companies based in Indiana Category:Agrochemical companies Category:1989 establishments in Indiana Category:1997 disestablishments in Indiana